1. Two years of denosumab and teriparatide administration in postmenopausal women with osteoporosis (The DATA Extension Study): A randomized controlled trial
LederBZ
TsaiJN
UihleinAV
Burnett-BowieS-AM
ZhuY
FoleyK
10.1210/jc.2013-4440J Clin Endocrinol Metab992014